Suppr超能文献

俄克拉荷马州州立医疗补助计划人群中 2012-2016 年处方类阿片类药物死亡概述。

Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016.

机构信息

Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK.

Purdue Pharma L.P., Stamford, CT.

出版信息

Med Care. 2018 Aug;56(8):727-735. doi: 10.1097/MLR.0000000000000944.

Abstract

BACKGROUND

Medicaid members are predisposed to unintentional prescription opioid overdose. However, little is known about their individual risk factors.

OBJECTIVES

To describe demographic and clinical characteristics, medical utilization, opioid use, concurrent use of benzodiazepines, risk factors, and substances involved in death for Oklahoma's Medicaid members who died of unintentional prescription opioid poisoning.

SUBJECTS

Decedents who were Medicaid eligible in Oklahoma during the year of death, had an opioid recorded in cause of death, and had ≥1 opioid prescription claim between January 1, 2011 and June 30, 2016 were cases. Controls were living Medicaid members and were matched 3:1 to cases through propensity score matching.

MEASURES

Demographics, clinical characteristics, and medical/pharmacy utilization were examined in the 12 months before the index date.

RESULTS

Of 639 members with fatal unintentional prescription opioid overdoses, 321 had ≥1 opioid prescription claim in the year before death; these were matched to 963 controls. Compared with controls, decedents had significantly greater proportions of nonopioid substance use disorders, opioid abuse/dependence, hepatitis, gastrointestinal bleeding, trauma not involving motor vehicle accidents, nonopioid poisonings, and mental illness disorders. Decedents had significantly higher daily morphine milligram equivalent doses (67.2±74.4 vs. 47.2±50.9 mg) and greater opioid/benzodiazepine overlap (70.4% vs. 35.9%). Benzodiazepines were involved in 29.3% of deaths.

CONCLUSIONS

Several comorbidities indicative of opioid use disorder and greater exposure to opioids and concomitant benzodiazepines were associated with unintentional prescription opioid overdose fatalities. Prescribers and state agencies should be aware of these addressable patient-level factors among the Medicaid population. Targeting these factors with appropriate policy interventions and education may prevent future deaths.

摘要

背景

医疗补助计划(Medicaid)成员易发生非故意处方类阿片类药物过量。然而,对于其个体风险因素知之甚少。

目的

描述俄克拉荷马州医疗补助计划成员中因非故意处方类阿片类药物中毒而死亡的个人的人口统计学和临床特征、医疗利用情况、阿片类药物使用情况、苯二氮䓬类药物同时使用情况、风险因素以及涉及的物质。

研究对象

在死亡当年符合医疗补助条件、死亡原因中记录有阿片类药物且在 2011 年 1 月 1 日至 2016 年 6 月 30 日期间至少有 1 次阿片类药物处方的死亡者为病例。对照为在世的医疗补助计划成员,并通过倾向评分匹配以 3:1 的比例与病例匹配。

测量指标

在指数日期前的 12 个月内检查人口统计学、临床特征和医疗/药房利用情况。

结果

在 639 名发生致命性非故意处方类阿片类药物过量的成员中,有 321 名在死亡前 1 年内至少有 1 次阿片类药物处方;这些人与 963 名对照进行了匹配。与对照相比,死者中患有非阿片类物质使用障碍、阿片类药物滥用/依赖、肝炎、胃肠道出血、非机动车事故引起的创伤、非阿片类药物中毒和精神疾病障碍的比例明显更高。死者的每日吗啡毫克当量剂量(67.2±74.4 与 47.2±50.9mg)和阿片类药物/苯二氮䓬类药物重叠率(70.4%与 35.9%)明显更高。苯二氮䓬类药物在 29.3%的死亡中涉及。

结论

几种合并症表明存在阿片类药物使用障碍,且接触阿片类药物和同时使用苯二氮䓬类药物的情况更严重,这与非故意处方类阿片类药物过量致死相关。医疗补助计划人群中的开处方者和州机构应了解这些可解决的患者水平因素。通过适当的政策干预和教育针对这些因素进行干预,可能会预防未来的死亡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验